Literature DB >> 8779930

Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes.

K Yasui1, P Palade.   

Abstract

Sphingosine, an endogenous phospholipid known to produce significant decreases in myoplasmic Ca2+ transients, was shown to have a pronounced inhibitory effect on inward Na+ and L-type Ca2+ currents in rat ventricular myocytes. Sphingosine action was accompanied by a slowing of inactivation of both kinds of current. Both sphingosine and sphingosylphosphorylcholine (SPC) caused depolarizing shifts in the activation curves for the two channels. In tests on Ca2+ currents, sphingosine neither showed high affinity for inactivated states nor exhibited any use dependence. The mechanism of the blocking action of sphingosine does not appear to involve effects on bulk surface charge or, at least for Ca2+ channels, a voltage-dependent block. Instead, the results appear most consistent with an effect of sphingosine on channel gating. The shift in the voltage dependence of channel activation by sphingosine and SPC appears likely to be a feature of both the hydrocarbon chains and the net positive charge of these amphiphiles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779930     DOI: 10.1152/ajpcell.1996.270.2.C645

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

2.  Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.

Authors:  Xin Qin; Zhichao Yue; Baonan Sun; Wenzhong Yang; Jia Xie; Eric Ni; Yi Feng; Rafat Mahmood; Yanhui Zhang; Lixia Yue
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

3.  Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner.

Authors:  A Bischoff; P Czyborra; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 4.  Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases.

Authors:  Di Ge; Hong-Wei Yue; Hong-Hong Liu; Jing Zhao
Journal:  Acta Pharmacol Sin       Date:  2018-07-26       Impact factor: 6.150

Review 5.  Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.

Authors:  Astrid E Alewijnse; Stephan L M Peters; Martin C Michel
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

6.  Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons.

Authors:  Y H Zhang; M R Vasko; G D Nicol
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

7.  Sphingosylphosphocholine modulates the ryanodine receptor/calcium-release channel of cardiac sarcoplasmic reticulum membranes.

Authors:  R Betto; A Teresi; F Turcato; G Salviati; R A Sabbadini; K Krown; C C Glembotski; L A Kindman; C Dettbarn; Y Pereon; K Yasui; P T Palade
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.